Sunny BioDiscovery (United States)
- World rank, all time
- #30,830 of 42,892
- Rank in United States
- #6,589 of 8,685
- Research works
- 157 ▼ 2% vs 2013–17
- Citations
- 3.1k 19.7 per fractional work
- Top-10% rate
- 14.6% record average 16.5%
- Open access
- 43% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.8×
- Biochemistry, Genetics and Molecular Biology 6.0×
- Immunology and Microbiology 4.6×
- Economics, Econometrics and Finance 3.4×
- Veterinary 2.5×
- Chemistry 2.0×
- Agricultural and Biological Sciences 1.8×
- Medicine 1.1×
- Neuroscience 0.8×
- Health Professions 0.8×
- Decision Sciences 0.8×
- Business, Management and Accounting 0.4×
- Environmental Science 0.4×
- Computer Science 0.4×
- Earth and Planetary Sciences 0.4×
- Engineering 0.4×
- Materials Science 0.3×
- Psychology 0.3×
- Dentistry 0.2×
- Physics and Astronomy 0.2×
Which keywords describe research at Sunny BioDiscovery (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Cancer Therapy, Monoclonal Antibodies, Pharmaceutical Industry, Medicinal Chemistry, Pharmacokinetics and Single-Cell Analysis.
- Tumor Microenvironment
- Private R&D
- Genetics
- Drug Development Costs
- Quality of Life
- Metabolic Engineering
- Chemotherapy
- Immunotherapy
- Clinical Trials
- Biomedical Applications
- Pharmacokinetics
- Medicinal Chemistry
- Oxidative Stress
- Gene Expression
- Innovation
- Cancer
- Inflammation
- Machine Learning
- Cancer Therapy
- Monoclonal Antibodies
- Economic Growth
- Pharmaceutical Industry
- Single-Cell Analysis
- Biopharmaceuticals
- Epidemiology
- Regulation
- Drug Discovery
- Metastatic
- Cost-effectiveness Analysis
- Generic Drugs
- Health Utility Measures
- R&D Subsidies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Inflammation3▲ 3.0×24 topics
- Cancer3▲ 4.3×18 topics
- Machine Learning2▲ 1.30×9 topics
- Innovation2▲ 3.6×4 topics
- Cancer Therapy2▲ 5.7×10 topics
- Gene Expression2▲ 5.0×7 topics
- Monoclonal Antibodies1▲ 31×2 topics
- Oxidative Stress1▲ 1.79×12 topics
- Economic Growth1▲ 3.2×2 topics
- Medicinal Chemistry1▲ 9.8×3 topics
- Pharmaceutical Industry1▲ 73×2 topics
- Pharmacokinetics1▲ 10×2 topics
- Single-Cell Analysis1▲ 48×2 topics
- Biomedical Applications1▲ 2.1×8 topics
- Biopharmaceuticals1▲ 47×2 topics
- Clinical Trials1▲ 3.6×4 topics
- Epidemiology1▼ 0.65×10 topics
- Immunotherapy1▲ 3.4×6 topics
- Regulation1▲ 4.4×5 topics
- Chemotherapy1▲ 3.2×4 topics
- Drug Discovery1▲ 9.8×6 topics
- Metabolic Engineering1▲ 23×4 topics
- Metastatic1▲ 35×2 topics
- Quality of Life1▲ 1.52×2 topics
- Cost-effectiveness Analysis1▲ 24×1 topic
- Drug Development Costs1▲ 79×1 topic
- Generic Drugs1▲ 79×1 topic
- Genetics1▲ 3.0×7 topics
- Health Utility Measures1▲ 24×1 topic
- Private R&D1▲ 107×1 topic
- R&D Subsidies1▲ 107×1 topic
- Tumor Microenvironment1▲ 4.9×5 topics
Which research topics does Sunny BioDiscovery (United States) publish most on?
By volume in 2022–2025: Innovation Policy and R&D, Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life and HER2/EGFR in Cancer Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Innovation Policy and R&D Economics and Econometrics 1 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 4 HER2/EGFR in Cancer Research Oncology 1 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 6 Global Health Care Issues General Health Professions 1 works
- 7 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 1 works
- 8 Biosimilars and Bioanalytical Methods Immunology 1 works
- 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 10 Bioinformatics and Genomic Networks Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sunny BioDiscovery (United States)'s research output changed?
Output in 2018–2022 was 2% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Santa Paula
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.